Literature DB >> 27392184

Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine.

Leticia Kuri-Cervantes1, Slim Fourati1, Glenda Canderan1, Rafick-Pierre Sekaly2.   

Abstract

Over the last three decades, a myriad of data has been generated regarding HIV/SIV evolution, immune evasion, immune response, and pathogenesis. Much of this data can be integrated and potentially used to generate a successful vaccine. Although individual approaches have begun to shed light on mechanisms involved in vaccine-conferred protection from infection, true correlates of protection have not yet been identified. The systems biology approach helps unify datasets generated using different techniques and broaden our understanding of HIV immunopathogenesis. Moreover, systems biology is a tool that can provide correlates of protection, which can be targeted for the production of a successful HIV vaccine.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27392184     DOI: 10.1016/j.coi.2016.06.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  5 in total

Review 1.  The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy.

Authors:  Jean-Pierre Routy; Bertrand Routy; Gina M Graziani; Vikram Mehraj
Journal:  Int J Tryptophan Res       Date:  2016-10-12

2.  Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection.

Authors:  Srivamshi Pittala; Kenneth Bagley; Jennifer A Schwartz; Eric P Brown; Joshua A Weiner; Ilia J Prado; Wenlei Zhang; Rong Xu; Ayuko Ota-Setlik; Ranajit Pal; Xiaoying Shen; Charles Beck; Guido Ferrari; George K Lewis; Celia C LaBranche; David C Montefiori; Georgia D Tomaras; Galit Alter; Mario Roederer; Timothy R Fouts; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  Mol Syst Biol       Date:  2019-05-02       Impact factor: 11.429

3.  Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques.

Authors:  Antonio Valentin; Cristina Bergamaschi; Margherita Rosati; Matthew Angel; Robert Burns; Mahesh Agarwal; Janina Gergen; Benjamin Petsch; Lidia Oostvogels; Edde Loeliger; Kara W Chew; Steven G Deeks; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

4.  Highlights from the HIV Research for Prevention Conference (R4P),: 17-21 October 2016, Chicago, IL, USA.

Authors:  Sandhya Vasan; Tanyaporn Wansom; Alexandra Schuetz; Shelly Krebs; Rasmi Thomas; Gustavao Kijak; Christina Polyak
Journal:  J Virus Erad       Date:  2017-04-01

5.  Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.

Authors:  Cristina Bergamaschi; Evangelos Terpos; Margherita Rosati; Matthew Angel; Jenifer Bear; Dimitris Stellas; Sevasti Karaliota; Filia Apostolakou; Tina Bagratuni; Dimitris Patseas; Sentiljana Gumeni; Ioannis P Trougakos; Meletios A Dimopoulos; Barbara K Felber; George N Pavlakis
Journal:  Cell Rep       Date:  2021-07-23       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.